No Data
limin group (002734.SZ) has repurchased 3.83% of its shares, spending approximately 0.1 billion yuan.
Limin Group (002734.SZ) announced that, as of October 31, 2024, the company has completed the repurchase program...
Limin Group (002734.SZ): The synthetic biology laboratory has been completely renovated and the new additional experimental equipment has arrived.
On November 5th, Limin Group (002734.SZ) stated on the investor interaction platform that the newly planned synthetic biology laboratory of the company has been renovated. The newly added experimental equipment has arrived and is currently being debugged and accepted. At the same time, the company has expanded cooperation with universities and research institutions, and some new projects have started pre-research and project evaluation. In the third quarter, the company obtained 7 new invention patents and 4 new utility model patents; as of September 30, 2024, a total of 138 invention patents, 134 utility model patents, and 15 design patents have been obtained.
Limin Group (002734.SZ) signed a strategic cooperation agreement with Changke Biology.
Gelonghui October 28th | Limin Group (002734.SZ) announced that on October 21, 2024, the company signed a "Strategic Cooperation Agreement" with Xiamen Changke Biological Engineering Co., Ltd. (referred to as "Changke Biology"), the two parties will jointly work on developing bacteriophage bio-pesticides based on synthetic biology technology and phage technology as underlying technologies, creating and developing novel agricultural phage bio-products for promotion and application. According to the agreement, the two parties will jointly create and develop new bacteriophage-based bio-pesticides; apply for registration certificates for bacteriophage bio-pesticides; collaborate on sales of bacteriophage products.
Limin shares: report for the third quarter of 2024
Limin Group (002734.SZ): The net income for the first three quarters was 51.1995 million yuan, a year-on-year increase of 132.76%.
Gelonghui October 27th｜Limin Group (002734.SZ) announced that in the first three quarters of 2024, revenue was 3.344 billion yuan, a decrease of 1.58% year-on-year; net income attributable to shareholders of the listed company was 51.1995 million yuan, a year-on-year increase of 132.76%, with basic earnings per share of 0.14 yuan.
limin group (002734.SZ) distributed 1.5 yuan per 10 shares for the semi-annual period, with a record date of October 17th.
limin group (002734.SZ) announced that the company will implement the interim equity distribution for the first half of 2024, with a distribution of 10...
What You Can Learn From Limin Group Co.,Ltd.'s (SZSE:002734) P/ENo Data
No Data
